NSD2 and plasma cell myeloma: For some time it was unclear whether FGFR3 or WHSC1 was the definitive oncogenic factor, however, ~25% of t(4;14) myelomas do not have the reciprocal FGFR3 translocation and lack FGFR3 expression (76, 77).